AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Search Results for: "Food and Drug Administration"

FDA Seeks Public Comment on Blood Donor Deferral Policy

Steve Morin blog post author standing in public health service uniform in front of flags.

Editor’s Note:Here is a guest blog from the Food and Drug Administration (FDA). On July 26, 2016, the Food and Drug Administration (FDA) issued a notice in the Federal Register titled “Blood Donor Deferral Policy for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products.” FDA issued a Final Guidance in…

2016 Marks the 20th Anniversary of the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents

AIDSinfo logo - resized

When is it time to start antiretroviral therapy (ART) and what HIV regimens offer the greatest chance of treatment success? For the past 20 years, practitioners caring for individuals with HIV have looked to the U.S. Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents for guidance on these…

FDA approves Epclusa for treatment of chronic Hepatitis C virus infection

FDA logo - cropped - May 2016

First regimen to treat all six major HCV genotypes The U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). For patients with moderate to severe cirrhosis (decompensated cirrhosis), Epclusa is approved for use in combination with the drug ribavirin….

LGBT Health: Celebrating Our Progress and Looking Ahead

HHS Pride blog image - cropped HER size - June 2016

Summary: Here at HHS, our support for LGBT health and wellbeing has spanned across the department. If there is a single thread which ties together the incredible work done by each member of the Health and Human Services family, it is the belief that every American deserves the same opportunity to live a healthy, happy…

Strengthening Federal Efforts on PrEP and PEP

PREP pill with woman - cropped June 2016

Improving knowledge about pre-exposure prophylaxis (PrEP) and access for those who need it most are national priorities. In order to promote and improve the dissemination of accurate information about PrEP, the Office of HIV/AIDS and Infectious Disease Policy (OHAIDP) and the Office of Minority Health (OMH) co-hosted a webinar on June 2, 2016 for Federal…

FDA Launches Campaign that Affirms LGBT Young Adults’ Freedom to Be, Tobacco Free

FDAThisFreeLife - cropped May 2016

Last week, I had the privilege of participating in the launch of “This Free Life,” the Food and Drug Administration’s (FDA) new anti-smoking campaign for lesbian, gay, bisexual and transgender (LGBT) young adults. This is FDA’s first-ever national campaign designed to prevent and reduce tobacco use among LGBT young adults (ages 18-24) who are occasional…

FDA approves Zepatier for treatment of chronic hepatitis C genotypes 1 and 4

FDA

The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. Hepatitis C is a viral disease that causes inflammation of the liver that can lead to diminished liver function or liver failure….

FDA updates blood donor deferral policy to reflect the most current scientific evidence and continue to ensure the safety of the U.S. blood supply

FDA

Today, the U.S. Food and Drug Administration issued final guidance outlining updated blood donor deferral recommendations to reflect the most current scientific evidence and to help ensure continued safety of the blood supply by reducing the risk of human immunodeficiency virus (HIV) transmission by blood and blood products. “The FDA’s responsibility is to maintain a…